Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.
D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology / Q000235:genetics*; D041321:Chromosomes, Human, X / Q000235:genetics; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D003430:Cross-Sectional Studies; D004252:DNA Mutational Analysis; D000795:Fabry Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology / Q000235:genetics*; D007231:Infant, Newborn; D008297:Male; D008487:Medical History Taking; D008875:Middle Aged; D015997:Neonatal Screening / Q000191:economics; D011237:Predictive Value of Tests; D025064:Sex Chromosome Disorders / Q000235:genetics; D000519:alpha-Galactosidase / Q000235:genetics
D000519:alpha-Galactosidase